重组人金属硫蛋白-Ⅲ联合创面敷料对小鼠全层皮肤缺损创面愈合的影响

沈鑫; 孙左义; 张瑞; 薛玉英

doi:10.3760/cma.j.cn501225-20231031-00164

重组人金属硫蛋白-Ⅲ联合创面敷料对小鼠全层皮肤缺损创面愈合的影响

doi: 10.3760/cma.j.cn501225-20231031-00164

东南大学公共卫生学院　　环境医学工程教育部重点实验室，南京　　210009

基金项目:

国家自然科学基金面上项目 82273674

详细信息

通讯作者:
薛玉英，Email：yyxue@seu.edu.cn

计量
- 文章访问数: 18
- HTML全文浏览量: 11
- PDF下载量: 1
- 被引次数: 0
出版历程
- 收稿日期: 2023-10-31
- 网络出版日期: 2024-04-29

Effects of recombinant human metallothionein-Ⅲ combined with wound dressing on wound healing of full-thickness skin defects in mice

Key Laboratory of Environmental Medicine and Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China

Funds:

General Program of National Natural Science Foundation of China 82273674

More Information

Corresponding author: Xue Yuying, Email: yyxue@seu.edu.cn

摘要

摘要: 目的探讨重组人金属硫蛋白Ⅲ（rh-MT-Ⅲ）联合创面敷料在小鼠全层皮肤缺损创面愈合的作用。方法该研究为实验研究。取24只6周龄ICR小鼠，雌雄各半，在每只小鼠背部制备2个对称的圆形全层皮肤缺损创面。将小鼠按性别、体重分层随机分为生理盐水组、敷料组、rh-MT-Ⅲ组（在创面涂布相应的溶液）和联合治疗组（在创面涂布rh-MT-Ⅲ和创面敷料的混合液），每组6只小鼠。伤后1~7 d，每天观察所有小鼠的活动、饮食和毛发生长变化，记录小鼠体重、创面面积并计算相对创面面积百分比。伤后7 d，取小鼠创面组织，行苏木精-伊红染色观察新生肉芽组织情况，行Masson染色观察胶原纤维沉积情况，行免疫荧光染色检测细胞增殖情况（以Ki67相对荧光强度表示）和细胞凋亡情况（以TUNEL相对荧光强度表示）。以上实验样本数均为6。结果伤后7 d内，4组小鼠均未观察到活动、饮食和毛发生长异常。伤后1~7 d，4组小鼠体重总体比较，差异均无统计学意义（ P>0.05）。联合治疗组小鼠伤后2、3、4、5、6、7 d相对创面面积百分比均明显低于生理盐水组、rh-MT-Ⅲ组（ P<0.05），伤后3、4、5、6、7 d相对创面面积百分比均明显低于敷料组（ P<0.05）。敷料组小鼠伤后6、7 d及rh-MT-Ⅲ组小鼠伤后7 d相对创面面积百分比均明显低于生理盐水组（ P<0.05）。伤后7 d，联合治疗组小鼠创面组织中可见大量毛细血管和成纤维细胞，且创面上缘新生上皮组织生长优于其他3组；联合治疗组小鼠创面组织中胶原纤维致密程度较其他3组更高且排列更为有序。伤后7 d，敷料组、rh-MT-Ⅲ组、联合治疗组小鼠创面组织中Ki67相对荧光强度为（289±35）%、（197±17）%、（389±56）%，均明显高于生理盐水组的（100±15）%（ P<0.05），联合治疗组小鼠创面组织中Ki67相对荧光强度明显高于敷料组、rh-MT-Ⅲ组（ P值均<0.05）。伤后7 d，敷料组、rh-MT-Ⅲ组、联合治疗组小鼠创面组织中TUNEL相对荧光强度为（55.5±5.7）%、（66.7±8.0）%、（20.0±2.2）%，均明显低于生理盐水组的（100.0±12.9）%（ P<0.05），联合治疗组小鼠创面组织中TUNEL相对荧光强度明显低于敷料组、rh-MT-Ⅲ组（ P值均<0.05）。结论 rh-MT-Ⅲ可协同创面敷料促进创面周围肉芽组织生长以及胶原沉积，还可提高细胞增殖活力，减少细胞凋亡，通过促进创面边缘皮肤再上皮化，从而加速小鼠全层皮肤缺损创面愈合。
- 金属硫蛋白 /
- 生物敷料 /
- 细胞增殖 /
- 细胞凋亡 /
- 创面修复
Abstract: Objective To investigate the effects of recombinant human metallothionein-Ⅲ (rh-MT-Ⅲ) combined with wound dressing on wound healing of full-thickness skin defects in mice. Methods This study was an experimental study. Twenty-four half male and half female 6 weeks old ICR mice were taken, and two symmetrical round full-thickness skin defect wounds were prepared on the back of each mouse. The mice were stratified and randomly divided into saline group, dressing group, rh-MT-Ⅲgroup (applying the corresponding solution on the wounds) and combined treatment group (applying a mixture of rh-MT-Ⅲ and wound dressing on the wounds) according to sex and body weight, with 6 mice in each group. From 1 to 7 d after injury, all mice were observed daily for changes in activity, diet, and fur growth, their body weights and wound areas were recorded, and the percentages of relative wound areas were calculated. On 7 d after injury, the wound tissue of mice was taken for hematoxylin-eosin staining to observe the newborn granulation tissue, for Masson staining to observe collagen fibre deposition, and for immunofluorescence staining to detect cell proliferation (expressed as Ki67 relative fluorescence intensity) and cell apoptosis (expressed as TUNEL relative fluorescence intensity). The sample size in the above experiments was 6. Results No abnormalities in activity, diet, and fur growth were observed in the 4 groups of mice within 7 d after injury. There was no statistically significant differences in the overall comparison of the body weights of mice in the 4 groups from 1 to 7 d after injury ( P>0.05). The relative wound area percentages of mice in combined treatment group were significantly lower than those in saline group and rh-MT-Ⅲ group on 2, 3, 4, 5, 6, and 7 d after injury ( P<0.05), and the relative wound area percentages of mice in combined treatment group were significantly lower than those in dressing group on 3, 4, 5, 6, and 7 d after injury ( P<0.05). The relative wound area percentages of mice in dressing group on 6 and 7 d after injury and in rh-MT-Ⅲ group on 7 d after injury were significantly lower than those in saline group ( P<0.05). On 7 d after injury, a large number of capillaries and fibroblasts could be seen in wound tissue of mice in combined treatment group, and the growth of new epithelial tissue at the upper edge of the wound was better than that of the other three groups; the collagen fibres in the wound tissue of mice in combined treatment group had the highest degree of density and arranged in a more orderly manner than those of the other three groups. On 7 d after injury, the relative fluorescence intensity of Ki67 in the wound tissue of mice in dressing group, rh-MT-Ⅲ group, and combined treatment group was (289±35)%, (197±17)%, and (389±56)%, which was significantly higher than (100±15)% of saline group, respectively ( P<0.05), and the relative fluorescence intensity of Ki67 in the wound tissue of mice in combined treatment group was significantly higher than that of dressing group and rh-MT-Ⅲ group ( P<0.05). On 7 d after injury, the relative fluorescence intensity of TUNEL in the wound tissue of mice in dressing group, rh-MT-Ⅲ group, and combined treatment group was (55.5±5.7)%, (66.7±8.0)%, and (20.0±2.2)%, which was significantly lower than (100.0±12.9)% in saline group, respectively ( P<0.05), and the relative fluorescence intensity of TUNEL in the wound tissue of mice in combined treatment group was significantly lower than that of dressing group and rh-MT-Ⅲ group, respectively ( P<0.05). Conclusions rh-MT-Ⅲ combined with wound dressing can promote the growth of granulation tissue around the wound as well as collagen deposition, increase the cell proliferation vitality, reduce cell apoptosis, and promote the re-epithelialization of skin at the edge of the wounds, thus accelerating the healing of full-thickness skin defect wounds in mice.
- Metallothionein /
- Biological dressings /
- Cell proliferation /
- Apoptosis /
- Wound repair
沈鑫：实施研究、起草文章、修改文章；孙左义：实施研究，对文章的知识性内容作批判性审阅；张瑞：分析并解释数据；薛玉英：研究指导、经费支持

所有作者均声明不存在利益冲突

HTML全文

下载: 全尺寸图片幻灯片

1 4组全层皮肤缺损小鼠伤后各时间点体重比较（样本数为6， x ¯ ± s）

注：生理盐水组、重组人金属硫蛋白-Ⅲ（rh-MT-Ⅲ）组、敷料组创面分别涂布相应的溶液，联合治疗组创面涂布rh-MT-Ⅲ和创面敷料的混合液；时间因素主效应，F=4.39，P=0.003；处理因素主效应，F=0.78，P=0.518；二者交互效应，F=0.41，P=0.957；伤后1、2、3、4、5、6、7 d，4组小鼠体重总体比较，差异均无统计学意义（F值分别为0.60、0.32、1.06、1.18、0.94、0.69、0.18，P值分别为0.623、0.809、0.390、0.343、0.442、0.568、0.911）

下载: 全尺寸图片幻灯片

2 4组全层皮肤缺损小鼠伤后各时间点创面愈合情况。2A、2B、2C、2D.分别为生理盐水组伤后1、3、5、7 d创面情况；2E、2F、2G、2H.分别为敷料组伤后1、3、5、7 d创面情况；2I、2J、2K、2L.分别为rh-MT-Ⅲ组伤后1、3、5、7 d创面情况；2M、2N、2O、2P.分别为联合治疗组伤后1、3、5、7 d创面情况，联合治疗组创面愈合速度快于其他3组

注：生理盐水组、重组人金属硫蛋白-Ⅲ（rh-MT-Ⅲ）组、敷料组创面分别涂布相应的溶液，联合治疗组创面涂布rh-MT-Ⅲ和创面敷料的混合液

下载: 全尺寸图片幻灯片

3 4组全层皮肤缺损小鼠伤后7 d创面组织病理学变化情况。3A、3B、3C、3D.分别为生理盐水组、敷料组、rh-MT-Ⅲ组及联合治疗组创面组织病理学变化情况，图3D新生肉芽组织、毛细血管和成纤维细胞（Fb）情况优于图3A、3B、3C 苏木精-伊红×100；3E、3F、3G、3H.分别为图3A、3B、3C、3D中方框部位放大图，图3H毛细血管和Fb数量明显多于图3E、3F、3G 苏木精-伊红×400

注：生理盐水组、重组人金属硫蛋白-Ⅲ（rh-MT-Ⅲ）组、敷料组创面分别涂布相应的溶液，联合治疗组创面涂布rh-MT-Ⅲ和创面敷料的混合液；黄色箭头指示成纤维细胞，红色箭头指示毛细血管

下载: 全尺寸图片幻灯片

4 4组全层皮肤缺损小鼠伤后7 d创面组织中胶原纤维形成情况。4A、4B、4C、4D.分别为生理盐水组、敷料组、rh-MT-Ⅲ组及联合治疗组胶原纤维形成情况，图4B、4C、4D胶原纤维沉积优于图4A Masson×100；4E、4F、4G、4H.分别为图4A、4B、4C、4D中方框部位放大图，图4H胶原纤维致密程度优于图4E、4F、4G Masson×400

注：生理盐水组、敷料组、重组人金属硫蛋白-Ⅲ（rh-MT-Ⅲ）组创面分别涂布相应的溶液，联合治疗组创面涂布rh-MT-Ⅲ和创面敷料的混合液；黄色箭头指示胶原纤维，红色箭头指示纤维蛋白

下载: 全尺寸图片幻灯片

5 4组全层皮肤缺损小鼠伤后7 d创面组织中Ki67荧光强度 Ki67-4'，6-二脒基-2-苯基吲哚×100。5A、5B、5C、5D.分别为生理盐水组、敷料组、rh-MT-Ⅲ组、联合治疗组，图5B、5C、5D中Ki67荧光强度明显高于图5A

注：生理盐水组、重组人金属硫蛋白-Ⅲ（rh-MT-Ⅲ）组、敷料组创面分别涂布相应的溶液，联合治疗组创面涂布rh-MT-Ⅲ和创面敷料的混合液；细胞核染色为蓝色，Ki67阳性染色为红色

下载: 全尺寸图片幻灯片

6 4组全层皮肤缺损小鼠伤后7 d创面组织中TUNEL荧光强度 TUNEL-4'，6-二脒基-2-苯基吲哚×100。6A、6B、6C、6D.分别为生理盐水组、敷料组、rh-MT-Ⅲ组、联合治疗组，图6B、6C、6D中TUNEL荧光强度明显低于图6A

注：生理盐水组、重组人金属硫蛋白-Ⅲ（rh-MT-Ⅲ）组、敷料组创面分别涂布相应的溶液，联合治疗组创面涂布rh-MT-Ⅲ和创面敷料的混合液；细胞核染色为蓝色，TUNEL阳性染色为绿色

下载: 全尺寸图片幻灯片

表1 4组全层皮肤缺损小鼠伤后各时间点相对创面面积百分比比较（%， x ¯ ± s ）

表1. Comparison of relative wound area percentage at various time points after injury in four groups of mice with full-thickness skin defects

组别	创面数	1 d	2 d	3 d	4 d	5 d	6 d	7 d
生理盐水组	6	100.0±12.7	81.4±5.7	63.2±7.6	47.7±5.8	39.2±4.5	35.7±4.1	33.4±2.7
敷料组	6	100.0±8.8	75.2±8.1	55.5±9.8	47.6±6.2	37.2±2.3	28.7±4.2 ^a	23.1±1.8 ^a
rh-MT-Ⅲ组	6	100.0±11.2	80.8±8.6	60.4±4.2	51.5±4.4	38.8±4.7	32.6±5.0	27.7±1.2 ^a
联合治疗组	6	100.0±5.0	66.8±9.7 ^ac	40.9±3.2 ^abc	30.9±1.8 ^abc	25.5±3.2 ^abc	20.0±2.1 ^abc	14.8±1.9 ^abc
F值		<0.01	4.10	13.20	21.36	17.61	17.54	93.68
P值		>0.999	0.020	P<0.001	P<0.001	P<0.001	P<0.001	P<0.001
注：生理盐水组、重组人金属硫蛋白（rh-MT-Ⅲ）组、敷料组创面分别涂布相应的溶液，联合治疗组创面涂布rh-MT-Ⅲ和创面敷料的混合液；时间因素主效应， F=563.49， P<0.001；处理因素主效应， F=24.09， P<0.001；二者交互效应， F=2.40， P=0.003；与生理盐水组相比， ^a P＜0.05；与敷料组相比， ^b P＜0.05；与rh-MT-Ⅲ组相比， ^c P＜0.05

下载: 导出CSV

参考文献(32)

[1]	王布雷白及多糖水凝胶促皮肤伤口愈合作用研究西安陕西师范大学 2022 DOI: 10.27292/d.cnki.gsxfu.2021.001160 王布雷. 白及多糖水凝胶促皮肤伤口愈合作用研究 [D]. 西安:陕西师范大学, 2022. DOI: 10.27292/d.cnki.gsxfu.2021.001160.
[2]	GuerraA,BelinhaJ,JorgeRN.Modelling skin wound healing angiogenesis: a review[J].J Theor Biol,2018,459:1-17.DOI: 10.1016/j.jtbi.2018.09.020.
[3]	KagiJH,ValeeBL.Metallothionein: a cadmium- and zinc-containing protein from equine renal cortex[J].J Biol Chem,1960,235:3460-3465.
[4]	LiuAL,ZhangZM,ZhuBF,et al.Metallothionein protects bone marrow stromal cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation[J].Cell Biol Int,2004,28(12):905-911.DOI: 10.1016/j.cellbi.2004.09.004.
[5]	CherianMG,JayasuryaA,BayBH.Metallothioneins in human tumors and potential roles in carcinogenesis[J].Mutat Res,2003,533(1/2):201-209.DOI: 10.1016/j.mrfmmm.2003.07.013.
[6]	CoyleP,PhilcoxJC,CareyLC,et al.Metallothionein: the multipurpose protein[J].Cell Mol Life Sci,2002,59(4):627-647.DOI: 10.1007/s00018-002-8454-2.
[7]	何婧雯,熊海容,王靖,等.金属硫蛋白的研究现状及进展[J].农产品加工(上半月),2019(9):72-75. DOI: 10.16693/j.cnki.1671-9646(X).2019.09.018.
[8]	YouHJ,LeeKJ,JeongHG.Overexpression of human metallothionein-III prevents hydrogen peroxide-induced oxidative stress in human fibroblasts[J].FEBS Lett,2002,521(1/2/3):175-179.DOI: 10.1016/s0014-5793(02)02870-3.
[9]	燕艳,季志会,杜伟,等.金属硫蛋白应用研究进展[J].东北农业大学学报,2010,41(7):150-154.DOI: 10.3969/j.issn.1005-9369.2010.07.030.
[10]	ZhangW,XieY,LiuW,et al.Role of metallothionein in post-burn inflammation[J].Inflammation,2016,39(2):768-774.DOI: 10.1007/s10753-016-0305-7.
[11]	LansdownAB.Metallothioneins: potential therapeutic aids for wound healing in the skin[J].Wound Repair Regen,2002,10(3):130-132.DOI: 10.1046/j.1524-475x.2002.20101.x.
[12]	薛燕.金属硫蛋白在皮肤疾病中的研究进展[J].中国美容医学,2013,22(17):1823-1826.DOI: 10.3969/j.issn.1008-6455.2013.17.031.
[13]	徐连春,尚剑,孙晔,等.银纳米颗粒及载银抗菌涂层的研究与进展[J].中国组织工程研究,2016,20(25):3793-3800.DOI: 10.3969/j.issn.2095-4344.2016.25.022.
[14]	AlemdaroğluC,DeğimZ,CelebiN,et al.An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor[J].Burns,2006,32(3):319-327.DOI: 10.1016/j.burns.2005.10.015.
[15]	王宏宇, 巴特, 周彪, 等. 不同途径应用人脐带间充质干细胞外泌体治疗小鼠全层皮肤缺损创面的效果[J]. 中华烧伤与创面修复杂志, 2024, 40(4): 314-322. DOI: 10.3760/cma.j.cn501225-20231123-00203.
[16]	姚梦云,张宁,张庆,等.白细胞介素4修饰的金纳米酶对糖尿病小鼠全层皮肤缺损的作用[J].中华烧伤与创面修复杂志,2023,39(1):15-24.DOI: 10.3760/cma.j.cn501225-20220630-00275.
[17]	谢军,毛玉洁,王思宇,等.紫草素对大鼠慢性皮肤溃疡创面愈合及新生血管形成的促进作用及其机制[J].解放军医学杂志,2022,47(1):39-45.DOI: 10.11855/j.issn.0577-7402.2022.01.0039.
[18]	PenkowaM,CarrascoJ,GiraltM,et al.CNS wound healing is severely depressed in metallothionein I- and II-deficient mice[J].J Neurosci,1999,19(7):2535-2545.DOI: 10.1523/JNEUROSCI.19-07-02535.1999.
[19]	MorelliniNM,GilesNL,ReaS,et al.Exogenous metallothionein-IIA promotes accelerated healing after a burn wound[J].Wound Repair Regen,2008,16(5):682-690.DOI: 10.1111/j.1524-475X.2008.00418.x.
[20]	AignerGP,PeerV,FiechtnerB,et al.Wound healing and Cadmium detoxification in the earthworm Lumbricus terrestris - a potential case for coelomocytes?[J].Front Immunol,2023,14:1272191.DOI: 10.3389/fimmu.2023.1272191.
[21]	SunZ,QinJ,YuanH,et al.Recombinant human metallothionein-III alleviates oxidative damage induced by copper and cadmium in Caenorhabditis elegans[J].J Appl Toxicol,2023,43(8):1242-1252.DOI: 10.1002/jat.4460.
[22]	Cortese-KrottMM,MünchowM,PirevE,et al.Silver ions induce oxidative stress and intracellular zinc release in human skin fibroblasts[J].Free Radic Biol Med,2009,47(11):1570-1577.DOI: 10.1016/j.freeradbiomed.2009.08.023.
[23]	PavlíkV,SobotkaL,PejchalJ,et al.Silver distribution in chronic wounds and the healing dynamics of chronic wounds treated with dressings containing silver and octenidine[J].FASEB J,2021,35(5):e21580.DOI: 10.1096/fj.202100065R.
[24]	LinX,JagadapillaiR,CaiJ,et al.Metallothionein induction attenuates the progression of lung injury in mice exposed to long-term intermittent hypoxia[J].Inflamm Res,2020,69(1):15-26.DOI: 10.1007/s00011-019-01287-z.
[25]	GurtnerGC, WernerS, BarrandonY, et al. Wound repair and regeneration[J]. Nature, 2008,453(7193):314-321. DOI: 10.1038/nature07039.
[26]	WangZ,ZhaoF,XuC,et al.Metabolic reprogramming in skin wound healing[J/OL].Burns Trauma,2024,12:tkad047[2023-10-31].https://pubmed.ncbi.nlm.nih.gov/38179472/.DOI: 10.1093/burnst/tkad047.
[27]	ManchandaM,TorresM,InuossaF,et al.Metabolic reprogramming and reliance in human skin wound healing[J].J Invest Dermatol,2023,143(10):2039-2051.e10.DOI: 10.1016/j.jid.2023.02.039.
[28]	EmingSA,MurrayPJ,PearceEJ.Metabolic orchestration of the wound healing response[J].Cell Metab,2021,33(9):1726-1743.DOI: 10.1016/j.cmet.2021.07.017.
[29]	韩莹,时玉峥,魏训东,等.Ki67法检测间充质干细胞对淋巴细胞增殖抑制能力[J].药物评价研究,2022,45(4):673-679.DOI: 10.7501/j.issn.1674-6376.2022.04.009.
[30]	李丽,牛钰清,陈菲,等.介绍一种细胞凋亡TUNEL检测与Ki-67 DAPI三色荧光染色操作流程[J].临床与实验病理学杂志,2019,35(8):980-981.DOI: 10.13315/j.cnki.cjcep.2019.08.026.
[31]	ChowdhuryD,AlrefaiH,Landero FigueroaJA,et al.Metallothionein 3 controls the phenotype and metabolic programming of alternatively activated macrophages[J].Cell Rep,2019,27(13):3873-3886.e7.DOI: 10.1016/j.celrep.2019.05.093.
[32]	ÅgrenMS,ChafranskaL,EriksenJO,et al.Spatial expression of metallothionein, matrix metalloproteinase-1 and Ki-67 in human epidermal wounds treated with zinc and determined by quantitative immunohistochemistry: a randomised double-blind trial[J].Eur J Cell Biol,2021,100(3):151147.DOI: 10.1016/j.ejcb.2020.151147.